Case Report: Prolonged VV-ECMO (111 Days) Support in a Patient With Severe COVID-19.
Front Med (Lausanne)
; 8: 681548, 2021.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1369671
ABSTRACT
Venovenous extracorporeal membrane oxygenation (VV-ECMO) may be a lifesaving rescue therapy for patients with severe coronavirus disease 2019 (COVID-19). However, little is known regarding the efficacy of prolonged ECMO (duration longer than 14 days) in patients with COVID-19. In this case report, we report the successful use of prolonged VV-ECMO (111 days) in a 61-year-old man with severe COVID-19. Given the high mortality rate of severe COVID-19, this case provided evidence for use of prolonged VV-ECMO as supportive care in patients with severe COVID-19.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Tipo de estudio:
Reporte de caso
Idioma:
Inglés
Revista:
Front Med (Lausanne)
Año:
2021
Tipo del documento:
Artículo
País de afiliación:
Fmed.2021.681548
Similares
MEDLINE
...
LILACS
LIS